Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial

Publication date: 3–9 April 2021Source: The Lancet, Volume 397, Issue 10281Author(s): Shahin Lockman, Sean S Brummel, Lauren Ziemba, Lynda Stranix-Chibanda, Katie McCarthy, Anne Coletti, Patrick Jean-Philippe, Ben Johnston, Chelsea Krotje, Lee Fairlie, Risa M Hoffman, Paul E Sax, Sikhulile Moyo, Nahida Chakhtoura, Jeffrey SA Stringer, Gaerolwe Masheto, Violet Korutaro, Haseena Cassim, Blandina T Mmbaga, Esau João
Source: The Lancet - Category: General Medicine Source Type: research